With this approval, HYQVIA [Immune Globulin Infusion 10% (human) with Recombinant Human Hyaluronidase] becomes the first and only facilitated subcutaneous immunoglobulin available in Japan to treat these disorders.

Lilly and Amgen Each Announce Major Expansions of US Manufacturing Sites

By Feliza Mirasol

December 6th 2024

Lilly is investing $3 billion to expand its recently acquired manufacturing facility in Wisconsin, while Amgen is investing $1 billion to expand its facility in North Carolina.

Datwyler NeoFlex Plungers for large volume biologics | © Datwyler

Coated Plungers for Large Volume Biologics

By Pharmaceutical Technology Editors

December 1st 2024

Datwyler has launched new coated plungers in its NeoFlex line that are suitable for large volume biologics.

TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

Novo Nordisk Aims to Invest $4.1 Billion to Expand Manufacturing Capacity in US

By Feliza Mirasol

June 27th 2024

This $4.1 billion investment to build a second fill/finish manufacturing facility in Clayton, N.C., boosts Novo Nordisk's current 2024 investments in production to $6.8 billion.

...

6 7 8 9 10

About Us

Advertise

Editorial Info

Editorial Advisory Board

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777